A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Recent news on Isoptin Sr




Par Pharmaceutical Reports Sales and Earnings for 2005  Feb 28, 2006
...and a non-cash charge of $5.8 million, after tax, for the impairment of assets related to Par's acquisition of the product registration to IsoptinĀ® SR. ... - Yahoo! News


This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional